You are here

Zealand Pharma

Lilly’s former small molecule head makes the leap to a rising biotech in obesity

Pharma Voice

Wed, 05/21/25 - 11:07 am

Zealand Pharma Hires Lilly Executive as Biotech Ramps Up in Obesity

MSN/Reuters

Wed, 04/23/25 - 10:27 pm

Roche builds in obesity with $5.3bn Zealand licensing deal

Pharmaphorum

Wed, 03/12/25 - 11:09 am

FDA rejects Zealand Pharma's GLP-2 analog in rare bowel disease

Fierce Biotech

Thu, 12/19/24 - 09:29 pm

short bowel syndrome

FDA knocks back Zealand's dasiglucagon once again

Pharmaphorum

Wed, 10/9/24 - 09:42 am

congenital hyperinsulinism

Weight-loss market to see 16 new drugs by 2029, report estimates

Reuters

Tue, 09/10/24 - 04:29 pm

Boehinger Ingelheim

Structure Therapeutics

Viking Therapeutics

Zealand Pharma brings in $1B to drive development of obesity drugs

First Word Pharma

Wed, 06/26/24 - 10:04 am

Obesity drug from Zealand shows potential in early trial

BioPharma Dive

Thu, 06/20/24 - 05:57 pm

clinical trials

Boehringer, Zealand Heat Up MASH Race With Strong Phase II Data

BioSpace

Fri, 06/7/24 - 11:17 am

Boehinger Ingelheim

Boehringer, Zealand’s GLP-1 MASH Data ‘Unintentionally’ Published by Medical Congress Website

BioSpace

Thu, 06/6/24 - 11:48 am

Boehringer Ingelheim

clinical trials

Zealand raises $212.5M to advance obesity pipeline

Clinical Trials Arena

Tue, 01/9/24 - 09:37 am

FDA ends busy year with three drug rejections

BioPharma Dive

Tue, 01/2/24 - 10:13 pm

Boehringer moves obesity therapy into phase 3

Pharmaphorum

Fri, 10/6/23 - 10:01 am

Boehringer Ingelheim

clinical trials

Spotlight – Nash in 2023 and beyond

EP Vantage

Thu, 08/3/23 - 10:03 am

Boehringer Ingelheim

Akero Therapeutics

Ionis Pharmaceuticals

Gilead Sciences

Ascletis Pharma

Boehringer's new data drop shows 19% weight loss for phase 2 obesity prospect

Fierce Biotech

Sun, 06/25/23 - 09:46 pm

Boehringer Ingelheim

clinical trials

Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial

BioSpace

Wed, 05/10/23 - 10:21 am

Boehringer Ingelheim

clinical trials

Boehringer signals intent in obesity

EP Vantage

Thu, 03/30/23 - 10:05 am

Boehringer Ingelheim

clinical trials

Zealand Pharma reports data from Phase III short bowel syndrome trial

Clinical Trials Arena

Mon, 10/3/22 - 10:03 am

clinical trials

short bowel syndrome

Zealand Pharma, Novo Nordisk Ink Licensing Pact For Diabetes Drug

Yahoo/Benzinga

Wed, 09/7/22 - 10:15 am

Key data catalysts for the industry’s small players

EP Vantage

Fri, 07/1/22 - 09:35 am

Intercept Pharma

atopic dermatitis

short bowel syndrome

Assembly Biosciences

Pages